Corpus Intelligence IC Memo — TULSA SPINE HOSPITAL 2026-04-26 04:03 UTC
IC Memo — TULSA SPINE HOSPITAL
Investment Committee Memorandum | OK | 38 beds | Grade D | EBITDA uplift $5.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TULSA SPINE HOSPITAL

CCN 370216 | TULSA, OK | 38 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

TULSA SPINE HOSPITAL is a 38-bed suburban community hospital in TULSA, OK with $69.5M in net patient revenue and a 11.6% operating margin. The hospital serves a payer mix of 34.4% Medicare, 8.6% Medicaid, and 57.0% commercial.

Thesis: Turnaround. Our ML models identify $5.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 11.6% to 18.9% (+736bps).

Net Revenue HCRIS$69.5M
Current EBITDA COMPUTED$8.0M
Operating Margin COMPUTED11.6%
Occupancy HCRIS15.9%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS19.0%
Distress Probability ML55.1%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
89
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of 11.6% places it above the state median. Among 89 size-comparable peers (19-76 beds), the median margin is -9.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (19-76), prioritizing same-state peers. 89 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TULSA SPINE HOSPITAL (Target)OK38$69.5M11.6%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
OKLAHOMA HEART HOSPITAL SOUTHOK43$148.5M-0.6%
OKLAHOMA SURGICAL HOSPITALOK74$146.2M17.7%
COMMUNITY HOSPITALOK45$143.9M21.7%
BASS BAPTIST HEALTH CENTEROK75$96.7M-18.6%
INTEGRIS CANADIAN VALLEY HOSPIOK66$84.9M4.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.5M+210bp18mo
Cost to Collect4.5%2.5%$1.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$846K+122bp9mo
Clean Claim Rate88.0%96.0%$44K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.5M
Cost to Collect
$1.4M
Denial Rate Reduction
$1.4M
A/R Days Reduction
$846K
Clean Claim Rate
$44K
Total EBITDA Uplift$5.1M
Current EBITDA$8.0M
+ RCM Uplift+$5.1M
Pro Forma EBITDA$13.2M
Current Margin11.6%
Pro Forma Margin18.9%
WC Released (1x)$2.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$12.4M$104.2M8.42x53.1%
Base (11x exit)10.0x11.0x$12.4M$118.7M9.59x57.2%
Bull Case9.0x11.0x$11.1M$139.6M12.53x65.8%
Bull (12x exit)9.0x12.0x$11.1M$155.5M13.97x69.5%
Bear Case11.0x10.0x$13.6M$74.6M5.48x40.5%
Bear (11x exit)11.0x11.0x$13.6M$86.5M6.36x44.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 15.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 55.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 89 hospitals with 19-76 beds
  • Same-state prioritization (n=90)
  • Comp margins: P25=-24.1% / P50=-9.8% / P75=3.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.